Derma Sciences (DSCI) Reports In-Line Q2 Loss of 23c/Share
Tweet Send to a Friend
Derma Sciences (NASDAQ: DSCI) reported Q2 EPS of ($0.23) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
